Clinical evaluation of the LIAISON® Borrelia burgdorferi assay, a new automated chemiluminescence immunoassay for the diagnosis of lyme disease.

被引：0
|
作者：
Bobba, G. [1 ]
Terhaar, P. J. [1 ]
Blocki, F. A. [1 ]
Schmidt, J. A. [1 ]
机构：
[1] DiaSorin Inc, Stillwater, OK USA
来源：
CLINICAL CHEMISTRY | 2007年 / 53卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
B-35
引用
收藏
页码：A64 / A64
页数：1
相关论文
共 50 条
  • [31] LIAISON LH - A new automated chemiluminescence immunoassay for the determination of luteinising hormone (lutropin) in human serum.
    Markowitz, G
    Engel, B
    Schlett, R
    Mack, M
    CLINICAL CHEMISTRY, 2000, 46 (06) : A45 - A45
  • [32] Evaluation of RevA, a Fibronectin-Binding Protein of Borrelia burgdorferi, as a Potential Vaccine Candidate for Lyme Disease
    Floden, Angela M.
    Gonzalez, Tammy
    Gaultney, Robert A.
    Brissette, Catherine A.
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (06) : 892 - 899
  • [33] DIAGNOSIS OF LYME BORRELIOSIS BY AN ENZYME-IMMUNOASSAY DETECTING IMMUNOGLOBULIN-G REACTIVE TO PURIFIED BORRELIA-BURGDORFERI CELL COMPONENTS
    BERGSTROM, S
    SJOSTEDT, A
    DOTEVALL, L
    KAIJSER, B
    EKSTRANDHAMMARSTROM, B
    WALLBERG, C
    SKOGMAN, G
    BARBOUR, AG
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (05) : 422 - 427
  • [34] Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents
    Lipsett, Susan C.
    Branda, John A.
    McAdam, Alexander J.
    Vernacchio, Louis
    Gordon, Caroline D.
    Gordon, Catherine R.
    Nigrovic, Lise E.
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (07) : 922 - 928
  • [35] Analysis of novel inhibitors of Borrelia burgdorferi BGP protein: Potential new antibiotics to treat lyme disease
    Firica, Tudor
    Lines, Elias
    Gonzalez, Jesus
    Schwarz, Sam
    Thurston, John
    Xu, Dong
    Cornell, Ken
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [36] MOLECULAR DIAGNOSIS OF BORRELIA-BURGDORFERI INFECTION (LYME-DISEASE) (VOL 11, PG 207, 1992)
    WILLIAMS, WV
    CALLEGARI, P
    FREUNDLICH, B
    KEENAN, G
    ELDRIDGE, D
    SHIN, H
    KREITMAN, M
    MCCALLUS, D
    WEINER, DB
    DNA AND CELL BIOLOGY, 1994, 13 (04) : 447 - 447
  • [37] Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease
    Lin, Yi-Pin
    Li, Lingyun
    Zhang, Fuming
    Linhardt, Robert J.
    MICROBIOLOGY-SGM, 2017, 163 (12): : 1759 - 1766
  • [38] Clinical evaluation of the two-test approach for Lyme disease.
    Blaauw, AAM
    vanLoon, AM
    Schellekens, J
    Bijlsma, JWJ
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 667 - 667
  • [39] A new mouse model for studying the interaction of the Lyme disease spirochete, Borrelia burgdorferi, with human skin.
    Van Solingen, RM
    Schechner, JS
    McNiff, JM
    Bockenstedt, LK
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S346 - S346
  • [40] A SPECIFIC AND SENSITIVE ASSAY FOR THE LYME-DISEASE SPIROCHETE BORRELIA-BURGDORFERI USING THE POLYMERASE CHAIN-REACTION
    ROSA, PA
    SCHWAN, TG
    JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (06): : 1018 - 1029
12345